Ogden Christopher
SEC insider (Form 3/4/5 filer). CIK 0001914523. Chief Financial Officer at CytomX Therapeutics, Inc. (CTMX). 11 reported Form 4/5 transactions since Sep 2024; latest on Jun 15, 2026. Located in SOUTH SAN FRANCISCO, CA.
Companies Ogden Christopher has filed insider reports for
- CytomX Therapeutics, Inc. (CTMX): Officer, Chief Financial Officer
Ogden Christopher
CIK: 0001914523
Transaction Breakdown
High conviction signal
Position reduction
Derivative conversions
Compensation grants
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
Companies & Roles (1)
CytomX Therapeutics, Inc.
Discretionary Trading P&L
Holdings
Transaction History (11 total)
- Jun 15, 2026CTMX
CytomX Therapeutics, Inc.
SaleDirect1.6K shares at avg. $3.05$5K - Mar 17, 2026CTMX
CytomX Therapeutics, Inc.
SaleDirect19.3K shares at avg. $6.42$124K - Feb 2, 2026CTMX
CytomX Therapeutics, Inc.
AwardDirect90K shares- - Sep 26, 2025CTMX
CytomX Therapeutics, Inc.
AwardDirectStock Option (Right to Buy)
78.3K shares- - Sep 26, 2025CTMX
CytomX Therapeutics, Inc.
AwardDirectPerformance Stock Units (PSUs)
39.2K shares- - Jun 16, 2025CTMX
CytomX Therapeutics, Inc.
SaleDirect10.6K shares at avg. $2.69$29K - Jun 13, 2025CTMX
CytomX Therapeutics, Inc.
ExerciseDirect37.5K shares- - Jun 13, 2025CTMX
CytomX Therapeutics, Inc.
SaleDirect1.6K shares at avg. $2.95$5K - Mar 18, 2025CTMX
CytomX Therapeutics, Inc.
SaleDirect8.6K shares at avg. $0.60$5K - Feb 4, 2025CTMX
CytomX Therapeutics, Inc.
AwardDirect57.5K shares-
| Type | Shares | Price | Ownership | |||
|---|---|---|---|---|---|---|
| Jun 15, 2026 | CTMX CytomX Therapeutics, Inc. | Sale | 1,624 | $3.05 | $4,953 | Direct |
| Mar 17, 2026 | CTMX CytomX Therapeutics, Inc. | Sale | 19,323 | $6.42 | $124,112 | Direct |
| Feb 2, 2026 | CTMX CytomX Therapeutics, Inc. | Award | 90,000 | - | $0 | Direct |
| Sep 26, 2025 | CTMX CytomX Therapeutics, Inc. | Award Stock Option (Right to Buy) | 78,250 | - | - | Direct |
| Sep 26, 2025 | CTMX CytomX Therapeutics, Inc. | Award Performance Stock Units (PSUs) | 39,150 | - | - | Direct |
| Jun 16, 2025 | CTMX CytomX Therapeutics, Inc. | Sale | 10,614 | $2.69 | $28,540 | Direct |
| Jun 13, 2025 | CTMX CytomX Therapeutics, Inc. | Exercise | 37,500 | - | - | Direct |
| Jun 13, 2025 | CTMX CytomX Therapeutics, Inc. | Sale | 1,641 | $2.95 | $4,841 | Direct |
| Mar 18, 2025 | CTMX CytomX Therapeutics, Inc. | Sale | 8,551 | $0.60 | $5,122 | Direct |
| Feb 4, 2025 | CTMX CytomX Therapeutics, Inc. | Award | 57,500 | - | - | Direct |
1-10 of 11 transactions